Posts Tagged ‘flibanserin’

The year in clinical sexuality, 2010

As we get ready to close the books on 2010, I would like to express my gratitude to  family,  friends, and colleagues for your support and encouragement over the past year.   And to all my patients for your trust and confidence.   May we all merit much happiness in 2011. In ending the year, [...]

The end of “Pink Viagra”:What have we learned?

(reprinted from Dr Snyder’s Another one bites the dust. As many of you know, this month the pharmaceutical firm Boehringer Ingelheim pulled the plug on flibanserin, the reputed (and as many have remarked, misnamed) “Pink Viagra,” which had been developed as a treatment for something called Hypoactive Sexual Desire Disorder (HSDD) in women. Many in [...]

Our sexual culture and The New York Times

The latest public figure to make journalistic hay from the flibanserin controversy is Camille Paglia, whose editorial in The New York Times, ”No Sex Please, We’re Middle Class, “ seems to be getting some play on my twitter feed.   It’s a fun read, but she throws a lot of things together that I’m not sure really [...]

Simplicity, complexity, and the hunt for Pink Viagra

Will there ever be a Viagra for women?    If so, would the FDA ever approve it?    How many women would actually want to try it? This month,  the U.S. Food and Drug Administration is expected to consider drug manufacturer Boehringer-Ingelheim’s new drug  flibanserin — a medication reported to somewhat improve female sexual desire. [...]